Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"Editorial"
topic_facet:"Tumor Necrosis Factor-alpha"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Editorial%22&filter%5B%5D=topic_facet%3A%22Tumor+Necrosis+Factor-alpha%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%221365-2036%22&type0%5B%5D=ISN&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Editorial%22&filter%5B%5D=topic_facet%3A%22Tumor+Necrosis+Factor-alpha%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%221365-2036%22&type0%5B%5D=ISN&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Editorial%22&filter%5B%5D=topic_facet%3A%22Tumor+Necrosis+Factor-alpha%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%221365-2036%22&type0%5B%5D=ISN&op0%5B%5D=OR
PubPharm (46)
1
Editorial : golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring-author's reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2023
von
Fumery, M.
|
Roblin, X.
CommentOn: Aliment Pharmacol Ther. 2023 Jun;57(11):1290-1298. - PMID 36849714
Wird geladen...
2
Editorial : golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring
enthalten in:
Alimentary pharmacology & therapeutics
| 2023
von
Hanzel, J.
|
Drobne, D.
CommentOn: Aliment Pharmacol Ther. 2023 Jun;57(11):1290-1298. - PMID 36849714
Wird geladen...
3
Editorial : the immunogenicity to second anti-TNF therapy (IMSAT) therapeutic drug monitoring study-defining the risk of the in-class switch
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Wilson, A.
CommentOn: Aliment Pharmacol Ther. 2022 Oct;56(8):1250-1263. - PMID 36039036
Wird geladen...
4
Editorial : golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Mantzaris, G.
|
Papamichael, K.
CommentOn: Aliment Pharmacol Ther. 2022 Aug;56(4):614-624. - PMID 35509152
Wird geladen...
5
Editorial : golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis-Author's reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Taxonera, C.
CommentOn: Aliment Pharmacol Ther. 2022 Aug;56(4):614-624. - PMID 35509152
Wird geladen...
6
Editorial : is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Rakowsky, S.
|
Cheifetz, A.
|
Papamichael, K.
CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):77-83. - PMID 35229331
Wird geladen...
7
Editorial : risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Goren, I.
|
Yanai, H.
CommentOn: Aliment Pharmacol Ther. 2021 Nov;54(10):1298-1308. - PMID 34559428
Wird geladen...
8
Editorial : does anti-TNF 'treatment persistence' always equate to 'effective treatment'? Only objective disease assessments can answer the question. Authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2021
von
Blesl, A.
|
Högenauer, C.
|
Borenich, A.
| +3
CommentOn: Aliment Pharmacol Ther. 2021 Sep;54(5):667-677. - PMID 34151449
Wird geladen...
9
Editorial : withdrawal of anti TNF-alpha - are we ready for biological therapy cycling?
enthalten in:
Alimentary pharmacology & therapeutics
| 2021
von
Pugliese, D.
|
Armuzzi, A.
CommentOn: Aliment Pharmacol Ther. 2021 Jun;53(12):1277-1288. - PMID 33962482
Wird geladen...
10
Editorial : total anti-drug antibodies detected using drug-tolerant assays during induction with anti-TNF therapy are associated with treatment failure-out of sight but not out of mind. Authors' reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2021
von
Roblin, X.
|
Nancey, S.
|
Paul, S.
CommentOn: Aliment Pharmacol Ther. 2021 Jun;53(11):1190-1200. - PMID 33872404
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Editorial
Filter aufheben
Thema: Tumor Necrosis Factor-alpha
Medienart
46
Aufsätze
46
E-Artikel
46
E-Ressourcen
Zeitschriftentitel
46
Alimentary pharmacology & therapeutics
Thema
Editorial
Tumor Necrosis Factor-alpha
45
Comment
12
B72HH48FLU
12
Infliximab
11
Antibodies, Monoclonal
6
Antibodies, Monoclonal, Humanized
6
Tumor Necrosis Factor Inhibitors
5
91X1KLU43E
5
9RV78Q2002
5
Research Support, Non-U.S. Gov't
5
golimumab
5
vedolizumab
3
Anti-Inflammatory Agents
3
Biological Products
3
Immunologic Factors
3
Immunosuppressive Agents
3
Pharmaceutical Preparations
2
Adalimumab
2
Antirheumatic Agents
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
20
2020-
26
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
46
Englisch
Haven't found what you're looking for?
Wird geladen...